Intelligent Bio Solutions Inc. said it has received and deployed the first shipment of Intelligent Fingerprinting Drug Screening Readers produced under its manufacturing partnership with Syrma Johari MedTech Ltd., with the units being deployed across construction, transportation and logistics, and manufacturing customers in the U.K. and Europe. The company said the partnership provides access to manufacturing capacity about four times its prior capability and is expected to generate annual production cost savings of more than 40%, supporting an expected gross margin improvement of about 20 percentage points annually. Intelligent Bio Solutions also said it has doubled in-house lateral flow test strip production capacity through new equipment, aiming to improve control of components, reduce lead times, increase cartridge output for R&D, and enable cartridges with additional test lines for expanded drug panels.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-007973), on February 25, 2026, and is solely responsible for the information contained therein.